Thermo Fisher Scientific INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NYSE
Thermo Fisher Scientific Inc. announced a 4% revenue increase and 7% diluted EPS growth in its 2025 annual report, driven by strategic acquisitions and productivity gains.
NYSE
Thermo Fisher Scientific's 2024 10-K filing reveals stable revenues despite a challenging macroeconomic environment and declining COVID-19 related sales, with strategic acquisitions and cost management initiatives playing key roles.
NYSE
Thermo Fisher Scientific updates its by-laws and files its annual report for the fiscal year ended December 31, 2023, detailing financial results and strategic initiatives.